Nebifast

Nebivolol Hydrochloride INN

Composition : Nebifast-2.5: Nebivolol INN 2.5 mg Tablet.

Nebifast-5: Nebivolol INN 5 mg Tablet.

Indications : Nebivolol tablets are indicated for the management of hypertension one of several preferred initial therapies in hypertensive patients with heart failure, post myocardial infarction, high CHD risk and diabetes mellitus.

Dosage and administration : Hypertension: 5 mg daily,elderly initially dose 2.5 mg daily, increased if necessary to 5 mg daily. Adjunct in heart failure: Initially 1.25 mg once daily, then if tolerated increased at intervals of 1-2 weeks to 2.5 mg once daily, then to 5 mg once daily, then to max. 10 mg once daily. Or, as directed by the registered physicians.

Packing : Nebifast-2.5 : 2X14's tablets in blister pack.

Nebifast-5 : 2X14's tablets in blister pack.


Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.